Fellowship · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
Imaging chronic active lesions in multiple sclerosis: a consensus statement.
Brain : a journal of neurology · 2024 · 172 citations · Daniel Harrison
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
The Lancet. Neurology · 2023 · 116 citations · John Corboy
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl.
Journal of addiction medicine · 2022 · 127 citations · Gregory Hobelmann
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
The Lancet. Neurology · 2023 · 105 citations · John Corboy
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.
Journal of addiction medicine · 2023 · 69 citations · Sarah Kawasaki
Social determinants of health in multiple sclerosis.
Nature reviews. Neurology · 2022 · 105 citations · Farrah Mateen
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.
Journal of psychopharmacology (Oxford, England) · 2023 · 53 citations · Denis Antoine
Detection and localization of early- and late-stage cancers using platelet RNA.
Cancer cell · 2022 · 115 citations · Farrah Mateen